Migraine

>

Latest News

Investigational PACAP Inhibitor Reduces Monthly Migraine Days, Lundbeck Reports / image credit stop headache concept: ©jiris/stock.adobe.com
Investigational PACAP Inhibitor Reduces Monthly Migraine Days, Lundbeck Reports

September 16th 2024

Individuals with migraine who failed to respond to up to 4 previous migraine preventive treatments saw fewer monthly migraine and headache days after 1 infusion of Lu AG90222.

Axsome Therapeutics: FDA Accepts NDA Resubmission for AXS-07 for Acute Treatment of Migraine
Axsome Therapeutics: FDA Accepts NDA Resubmission for AXS-07 for Acute Treatment of Migraine

September 16th 2024

AbbVie Announces Late Breaking Data at AAN to Support Atogepant Long-Term Safety, Efficacy for Migraine Prevention / image credit head pain ©jiris/stock.adobe.com
AbbVie Announces Late Breaking Data at AAN to Support Atogepant Long-Term Safety, Efficacy for Migraine Prevention

April 12th 2024

Consider CGRP Inhibitors as a First-Line Option for Preventive Treatment of Migraine: New American Headache Society Consensus Statement / image credit - headache: ©peterschreiber.media/stock.adobe.com
Consider CGRP Inhibitors as a First-Line Option for Preventive Treatment of Migraine: New American Headache Society Consensus Statement

April 12th 2024

Atogepant vs Rimegepant for Migraine Prevention: Daily Dose / image credit: ©New Africa/AdobeStock
Atogepant vs Rimegepant for Migraine Prevention: Daily Dose

April 11th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.